Molecular detection and genetic characterization of Resistance Genes in Shigella spp isolates Al-Diwaniyah city
DOI:
https://doi.org/10.61841/npja0p84Keywords:
Shigella spp, Antimicrobial Resistance, Resistance Genes, Shigella speciesAbstract
Development of antibiotics resistance in bacteria, consider as a part of evolutionary process in them has now been declared as a matter of global crisis by the World Health Organization ,It has resulted in increased failure rates of treatment of infectious diseases caused by bacteria, as drugs to which they were previously susceptible no longer works. Bacteria can be intrinsically resistant owning to its resistant mechanisms.aim of current study to detection and genetics characterization of resistance genes in Shigella spp. Shigella isolates were ) . The ereB , ereA , OXA bla , 15-M-CTX bla ( including resistance genes investigated genotypically for harboring (60%). ereB (45%) , ereA (70%) , OXA bla (60%) , 15-M-CTX bla current study recorded the highest prevalen
Downloads
References
1. Qu M, Zhang X, Liu G, Huang Y, Jia L, Liang W, Li X, Wu X, Li J, Yan H, Kan B, Wang Q. (2014) An eight-year study of Shigella species in Beijing, China: serodiversity, virulence genes, and antimicrobial resistance. J Infect Dev Ctries. 2014;8(7):904–8.
2. Raja S.B., Murali M.R., Roopa K. and Devaraj S.N. (2011) Imperatorin a furocoumarin inhibits periplasmic Cu-Zn SOD of Shigella dysenteriae thereby modulates its resistance towards phagocytosis during host-pathogen interaction. Biomedicine & Pharmacotherapy. 65(8):560–568.
3. Chompook P. (2011) Shigellosis. Encyclopedia of Environmental Health. pp. 26–32.
4. Roger FG, Greenwood D, Norbby SR, Whitley RJ. (2003) Antibiotic and Chemotherapy, The problem of resistance, 8th ed. Churchill Livingstone; p. 25–47.
5. Blair J.M.A., Webber M.A., Baylay A.J., Ogbolu D.O., Piddock L.J.V. (2018). Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol, 13:42–51.
6. Huang IF, Chiu CH, Wang MH, Wu CY, Hsieh KS, Chiou CC. (2005). Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: first report of plasmid-mediated CMY-2-type AmpC beta-lactamase resistance in S. sonnei. J Clin Microbiol. 43(6):2608–2612.
7. Jose M. Munita and Cesar A. Arias (2016). Mechanisms of Antibiotic Resistance. Microbiol Spectr. 4(2):10.1128/microbiolspec.VMBF-0016-2015.
8. Sabra AH, Araj GF, Kattar MM, Abi-Rached RY, Khairallah MT, Klena JD, Matar GM. (2009) Molecular characterization of ESBL-producing Shigella sonnei isolates from patients with bacillary dysentery in Lebanon. J Infect Dev Ctries. 3(4):300–5.
9. Rahman M*, AKM, Fahmidul H, Iztiba M.D, Dilruba A, Tanha Z, Afrina H Ru, Mahmuda Akter, Fatema Akter, K A Talukder (2017). Emergence of Extensively Drug-resistant Shigella sonnei in Bangladesh. Immunology and Infectious Diseases 5(1):1-9.
10. Canton R., Coque T.M. (2006) The CTX-M beta-lactamase pandemic. Curr Opin Microbiol. 9:466–475.
11. Behrooozi A., Rahbar M., Yousefi J.V. (2010) Frequency of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebsiella pneumoniae isolated from urine in an Iranian 1000-bed tertiary care hospital. Afr J Microbiol Res. 4:881–884.
12. Kariuki S, Muthotho N, Kimari J, Waiyaki P, Hart CA, Gilks CF (1996) Molecular typing of multidrug resistant Shigella dysenteriae type 1 by plasmid analysis and pulsed field gel electrophoresis. Trans R Soc Trop Med Hyg 90:712–714.
13. Levesque C, Pich L, Larose C, Roy PH (1995) PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 39:185–191.
14. Qian Huimin, Guoye Liu, Yin Chen, Ping Ma, Xiaoxiao Kong, Lu Zhou, Jie Hong, Changjun Bao, Bing Gu. (2018). Increasing clinical resistance rate of Shigella sonnei to cefotaxime in Jiangsu Province, China, 2012–2015.
15. Ranjbar R., Farzaneh M.G., Shohreh F., Giovanni M.G., Aurora A., Parviz O., Nematollah J., Nourkhoda S., Caterina M. (2013). Extended-spectrum β-lactamase producing Shigella spp. in Tehran, Iran. Iran J Microbiol. 5(2):108–112.
16. Taneja N, Mewara A, Kumar A, Verma G, Sharma M. (2012) Cephalosporin-resistant Shigella flexneri over 9 years (2001–09) in India. J Antimicrob Chemother. 67:1347–53.
17. Parajuli N.P., Joshi G., Pardhe B.D., Shakya J., Bhetwal A., Shakya S., Pandit R., Shrestha S.S., Khanal P.R. (2017). Shigellosis caused by CTX-M Type ESBL producing Shigella flexneri in two siblings of rural Nepal: First case report. Case Reports in Infectious Diseases 2017.
18. Zhang C–L, Liu Q–Z, Wang J, Chu Xu, Shen Li-M, Guo Y-Yu (2014). Epidemic and virulence characteristics of Shigella spp. with extended-spectrum cephalosporin resistance in Xiaoshan District, Hangzhou, China. BMC Infectious Diseases 14:260.
19. Wang Y, Ma Q, Hao R, Zhang Q, Yao S, Han J, Ren B, Fan T, Chen L, Xu X, Qiu Sh, Yang H (2019). Antimicrobial resistance and genetic characterization of Shigella spp. in Shanxi Province, China (2006–2016). BMC Microbiology 19:116.
20. Sethuvel DPM, Perumalla S, Anandan S, Michael JS, Kumar N, Ragupathi D, Gajendran R, Walia K, Veeraraghavan B (2019). Antimicrobial resistance, virulence & plasmid profiles among clinical isolates of Shigella serogroups. Indian J Med Res. 149:247–256.
21. Poirel L., Naas T., Nordmann P. (2010). Diversity, Epidemiology, and Genetics of Class D β-Lactamases. Antimicrob Agents Chemother. 54(1):24–38.
22. Peirano G., Agersø Y., Frank M. Aarestrup, Dalia dos Prazeres Rodrigues (2005). Integrons and resistance genes among sulphonamide-resistant Shigella spp. from Brazil. J Antimicrob Chemother. 55:301–305.
23. Ashraf M. Ahmed, Furuta K., Kei Sh., Kasama Y., Shimamoto T. (2006). Genetic characterization of multidrug resistance in Shigella spp. from Japan. J Med Microbiol. 55:1685–1691.
24. Zhu Z, Cao M, Zhou X, Li B, Zhang J (2017). Epidemic characterization and molecular genotyping of Shigella flexneri isolated from calves with diarrhea in Northwest China. Antimicrobial Resistance and Infection Control 6:92.
25. Zaidi M.B., Estrada-García T., Campos F.D., Chim R., Arjona F., Leon M., Michell A., Chaussabe D. (2013). Incidence, clinical presentation, and antimicrobial resistance trends in Salmonella and Shigella infections in children in Yucatan, Mexico. Frontiers in Microbiology, 4:288.
26. Shafia S., Praneeth Chandluri, Ramesh Ganpisetti, Dr. B.V.S. Lakshmi, Dr. P. Aravinda Swami (2016). Erythromycin use as broad spectrum antibiotic. World Journal of Pharmaceutical and Medical Research.
27. Bourtchai L.B., Kurkdjian P.M., Bingen E., Fillio I., Dhalluin A., Ifrane S.A., Weill F–X., Leclercq R. (2008). Macrolide-Resistant Shigella sonnei. Emerging Infectious Diseases, 14(8).
28. Honma Y., Sasakawa C., Tsuji T., Iwanaga M. (2000). Effect of erythromycin on Shigella infection of Caco-2 cells. FEMS Immunology & Medical Microbiology, 27(2):139–145.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
